Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $20,968 - $30,120
-163 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $844 - $990
6 Added 3.82%
163 $27,000
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $632 - $864
-6 Reduced 3.68%
157 $22,000
Q2 2020

Aug 04, 2020

SELL
$95.68 - $121.88 $287 - $365
-3 Reduced 1.81%
163 $18,000
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $1,140 - $1,985
-13 Reduced 7.26%
166 $17,000
Q1 2019

Apr 26, 2019

BUY
$121.81 - $142.95 $3,897 - $4,574
32 Added 21.77%
179 $26,000
Q4 2018

Jan 25, 2019

SELL
$115.94 - $166.74 $579 - $833
-5 Reduced 3.29%
147 $18,000
Q3 2018

Oct 26, 2018

BUY
$161.01 - $180.57 $805 - $902
5 Added 3.4%
152 $26,000
Q4 2017

Jan 26, 2018

SELL
$131.06 - $150.39 $917 - $1,052
-7 Reduced 4.55%
147 $20,000
Q3 2017

Oct 27, 2017

BUY
$142.62 - $155.6 $21,963 - $23,962
154
154 $23,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Enterprise Financial Services Corp Portfolio

Follow Enterprise Financial Services Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.